- Home
- KVYO vs PCVX Comparison
KVYO vs PCVX Comparison
Compare KVYO & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVYO
- PCVX
- Stock Information
- Founded
- KVYO 2012
- PCVX 2013
- Country
- KVYO United States
- PCVX United States
- Employees
- KVYO N/A
- PCVX N/A
- Industry
- KVYO
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- KVYO
- PCVX Health Care
- Exchange
- KVYO Nasdaq
- PCVX Nasdaq
- Market Cap
- KVYO 10.6B
- PCVX 11.5B
- IPO Year
- KVYO 2023
- PCVX 2020
- Fundamental
- Price
- KVYO $41.85
- PCVX $79.74
- Analyst Decision
- KVYO Buy
- PCVX Strong Buy
- Analyst Count
- KVYO 19
- PCVX 8
- Target Price
- KVYO $48.74
- PCVX $127.71
- AVG Volume (30 Days)
- KVYO 1.7M
- PCVX 913.0K
- Earning Date
- KVYO 02-19-2025
- PCVX 02-25-2025
- Dividend Yield
- KVYO N/A
- PCVX N/A
- EPS Growth
- KVYO N/A
- PCVX N/A
- EPS
- KVYO N/A
- PCVX N/A
- Revenue
- KVYO $937,464,000.00
- PCVX N/A
- Revenue This Year
- KVYO $35.08
- PCVX N/A
- Revenue Next Year
- KVYO $24.92
- PCVX N/A
- P/E Ratio
- KVYO N/A
- PCVX N/A
- Revenue Growth
- KVYO 34.29
- PCVX N/A
- 52 Week Low
- KVYO $21.26
- PCVX $58.10
- 52 Week High
- KVYO $49.55
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- KVYO 38.15
- PCVX 36.96
- Support Level
- KVYO $39.39
- PCVX $82.03
- Resistance Level
- KVYO $48.17
- PCVX $84.10
- Average True Range (ATR)
- KVYO 2.18
- PCVX 3.12
- MACD
- KVYO -0.70
- PCVX -0.70
- Stochastic Oscillator
- KVYO 24.18
- PCVX 1.88
About KVYO Klaviyo Inc. Series A
Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.